ClinicalTrials.gg
Sign In
Biological

Solizmestrocel clinical trials

Also written Human umbilical cord mesenchymal stem cells and UMC119-06.

studies test it
93
open now
28
in phase 3
7
first study started
2010

How each study uses solizmestrocel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the solizmestrocel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Umbilical Cord Mesenchymal Stem Cells
30
hUC-MSC
5
mesenchymal stem cells
5
Umbilical Cord-Derived Mesenchymal Stem Cells
4
Human Umbilical Cord Mesenchymal Stem Cells Injection
3

Development codes

UMC119-06
5
UMSC01
1
YB-1113
1

Other names

Human umbilical cord mesenchymal stem cells
26
UC-MSC
10
hUC-MSCs
5

Studies by the year they started

93 studies that test it; most in 2021 (10)

Studies that test solizmestrocel, by start year
YearStudies
20106
20113
20123
20134
20146
20152
20166
20184
20196
20208
202110
20226
20236
202410
20256
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
64
Phase 2
58
Phase 3
7
Phase 4
2
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Ischemic Stroke
5
Muscular Dystrophy, Duchenne
4
Osteoarthritis, Knee
4
Spinal Cord Injuries
4
Diabetes Mellitus, Type 2
3
Respiratory Distress Syndrome
3
Liver Cirrhosis
3
Frailty
2
Stroke
2
Arthritis, Rheumatoid
2
Keloid
2
Cardiomyopathy, Dilated
2

Who runs them

Industry 38 · Other 55

Shanghai East Hospital (8) · PT. Prodia Stem Cell Indonesia (5) · Meridigen Biotech Co., Ltd. (5) · Shenzhen Beike Bio-Technology Co., Ltd. (5) · Qingdao University (5) · Shenzhen Hornetcorn Bio-technology Company, LTD (4) · Translational Biosciences (3) · Asia Cell Therapeutics (Shanghai) Co., Ltd. (3)

Often tested with

Tested in the same studies.

Culture Media, Conditioned (3) · Platelet rich plasma (1) · Interleukin-2 (1) · Bone Marrow-Derived Mononuclear Cells (1) · Hormone Replacement Therapy (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 9

Studies that test solizmestrocel.

Studies

Open first, then newest update. How each study uses solizmestrocel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 93

See all 93 studies that test solizmestrocel →

As the comparator · 2 — what is tested is compared with solizmestrocel

Codes

What other systems call solizmestrocel · ClinicalTrials.gg INT016637

  • UNII (FDA) G64F59W88VSOLIZMESTROCELOne source FDA
  • NCI Thesaurus C203133SolizmestrocelOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.